<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40783853</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1009-3591</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Zhonghua nan ke xue = National journal of andrology</Title><ISOAbbreviation>Zhonghua Nan Ke Xue</ISOAbbreviation></Journal><ArticleTitle>[Different combinations of anesthetics in transperineal prostate biopsy in elderly men: A prospective, randomized, controlled monocentric trial].</ArticleTitle><Pagination><StartPage>896</StartPage><EndPage>902</EndPage><MedlinePgn>896-902</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the clinical effects of different combinations of anesthetics in transperineal prostate biopsy in elderly male patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We randomly divided 132 &#x2265;65-year-old male patients to receive transperineal prostate biopsy under combined intravenous anesthesia with propofol + sufentanil (the PS group), remimazolam + sufentanil (the RS group), propofol + alfentanil (the PA group), or remimazolam + alfentanil (the RA group). We recorded the mean arterial pressure (MAP) and heart rate (HR) of the patients, the required rescue sedation, the Richmond Agitation-Sedation Scale (RASS) scores upon admission into the postanesthesia care unit (PACU) after surgery, the length of stay in the PACU and the incidence of adverse reactions, followed by comparison of the data obtained among the four groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Operations were successfully completed in all the patients. At 5 moment points from T3 to t2, RA and RS groups had less effect on MAP than PA and PS groups (P &lt; 0.05); at 5 moment points from T1 to T5, RA and RS groups had less effect on HR than PA and PS groups (P&lt;0.05), and this effect was more obvious in RA group than in RS group.During anesthesia-induction, the incidence rate of injection pain was remarkably lower in the RA and RS than in the PA and PS groups (P&lt;0.05), and that of respiratory depression was higher in the PS than in the other three groups (P = 0.013). The RASS scores were significantly higher (P&lt;0.05) and the PACU stay shorter in the RA and RS than in the PA and PS groups (P&lt;0.05). Dramatically more cases of intraoperative body movement and remedial medication requirement were observed in the former than in the latter two groups (P = 0.013), but there was no statistically significant difference in the dose of remedial medication between the four groups of patients (P &gt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">For elderly male patients undergoing transperineal prostate biopsy under intravenous anesthesia with preservation of spontaneous breathing, the combined use of remimazolam and alfentanil can achieve more stable intraoperative hemodynamics, faster recovery from anesthesia and a lower incidence of perioperative adverse reactions, and produce an even better anesthetic effect with a small dose of propofol to suppress the body movement at the time of needle puncture.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Chen-Dong</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology&#xff0c; The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University&#xff0c; Changzhou, Jiangsu 213003&#xff0c; China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology&#xff0c; The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University&#xff0c; Changzhou, Jiangsu 213003&#xff0c; China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yi-Min</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology&#xff0c; The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University&#xff0c; Changzhou, Jiangsu 213003&#xff0c; China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital for Skin Diseases&#xff0c; Institute of Dermatology&#xff0c; Chinese Academy of Medical Sciences and Peking Union Medical College&#xff0c; Nanjing, Jiangsu 210042&#xff0c; China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Nan Ke Xue</MedlineTA><NlmUniqueID>101093592</NlmUniqueID><ISSNLinking>1009-3591</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AFE2YW0IIZ</RegistryNumber><NameOfSubstance UI="D017409">Sufentanil</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>1N74HM2BS7</RegistryNumber><NameOfSubstance UI="D015760">Alfentanil</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011467" MajorTopicYN="Y">Prostate</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017409" MajorTopicYN="N">Sufentanil</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="N">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015760" MajorTopicYN="N">Alfentanil</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000771" MajorTopicYN="N">Anesthesia, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">remimazolam; alfentanil; combination of anesthetics; elderly men; prostate needle biopsy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>10</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>10</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>10</Day><Hour>10</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40783853</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>